INSIGHTS AND PERSPECTIVES

THOUSAND OAKS, Calif. — A cancer drug made by Amgen reduced the chances of prostate cancer spreading to the bones, according to results of a late-stage clinical trial presented at the American Urological Association’s annual meeting in Washington.

The phase-3 “Study ‘147” of Xgeva (denosumab) showed that men taking the drug survived for four months longer without the cancer spreading to their bones, compared with those taking placebo.

ORLANDO, Fla. — Cancer drugs are expected to see sharp increases in spending and use by 2013, according to the latest drug trend report by pharmacy benefit manager Medco Health Solutions.

The overall drug trend for 2010 was 3.7%, lowered by higher rates of generic drug dispensing; more than 71% of drugs dispensed were generics. Specialty drugs, mostly branded biologics, accounted for 70.1% of the overall drug trend, with especially strong growth in cancer drugs, whose drug trend reached 21.2%.

BRISBANE, Calif. — An investigational drug made by InterMune improved breathing in patients with a rare and fatal lung disease, according to results of a late-stage clinical trial published online in The Lancet last week.

InterMune is investigating the drug pirfenidone as a treatment for idiopathic pulmonary fibrosis, which affects more than 200,000 patients in the European Union and the United States combined. Only 20% of patients with IPF survive after five years.

WASHINGTON — More than 25% of American women are focused on and proactive about their health and well-being, according to a national study released last week by “Life…supplemented.”

NEW YORK — Diabetics that have trouble sleeping likely experience high insulin resistance and have a more difficult time controlling the disease, according to study findings published in the June issue of Diabetes Care.

Researchers said they monitored the sleep of 40 subjects with diabetes for a duration of six nights and also measured the subjects' insulin and glucose levels during clinical examinations. The subjects also reported if they generally suffered from symptoms of such sleep disturbances as insomnia, snoring or sleep apnea.

WHAT IT MEANS AND WHY IT'S IMPORTANT — As reported, CVS Caremark's annual meeting of stockholders was of special importance as it marked the beginning of a new chapter for both CVS Caremark and its former chairman and CEO Tom Ryan, who officially retired from the company after more than 30 years of service.

(THE NEWS: CVS' Merlo outlines factors for future growth. For the full story, click here)

CHICAGO — In the wake of the turbulent economy, the cosmetic and skin care market, while not yet thriving, is showing signs of improvement. And drug stores and mass merchandisers prove to be the most popular channels for cosmetic purchasing, according to a recent Mintel survey.

WASHINGTON — More than 800 drugs are in development for diseases that affect women, according to a pharmaceutical industry lobbying group.